Ozan Pamir is the Chief Financial Officer at NIAGEN BIOSCIENCE INC., a leading biotechnology company focused on developing innovative therapies for various diseases. With over 15 years of experience in finance and strategic planning, Pamir has played a crucial role in guiding NIAGEN BIOSCIENCE INC. through its growth and expansion phases. Prior to joining the company, he held senior financial positions at several multinational corporations, where he honed his skills in financial management, risk assessment, and corporate strategy. Pamir's professional journey began after earning his MBA from a prestigious business school, where he specialized in finance and corporate strategy. His career trajectory saw him working with top-tier firms in the pharmaceutical and biotech industries, where he was instrumental in driving financial performance and operational efficiency. One of his notable achievements includes leading a successful financial restructuring at a major biotech firm, which resulted in significant cost savings and improved profitability. His expertise in navigating complex financial landscapes has made him an invaluable asset to NIAGEN BIOSCIENCE INC. As CFO at NIAGEN BIOSCIENCE INC., Ozan Pamir is responsible for overseeing the company's financial operations, including budgeting, forecasting, and investor relations. He works closely with the executive team to develop and implement strategic initiatives that support the company's long-term goals. Under his leadership, NIAGEN BIOSCIENCE INC. has secured substantial funding for research and development, enabling the company to advance its pipeline of promising therapies. Pamir's strategic vision and financial acumen continue to drive the company's success and position it as a leader in the biotechnology sector.